Home » Vaxart Says COVID-19 Vaccine Selected for Operation Warp Speed
Vaxart Says COVID-19 Vaccine Selected for Operation Warp Speed
Vaxart has announced that its COVID-19 vaccine has been selected to participate in an animal study on primates funded by the Trump administration’s Operation Warp Speed.
The California-based drugmaker is developing an oral COVID-19 vaccine, which would be administered by tablet rather than injection.
The vaccine candidate is stable at room temperature, which offers “an enormous logistical advantage in large vaccination campaigns,” the company said.
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May